
Analysis of Mirum Pharmaceuticals (MIRM) options highlights specific strategies for investors. Selling the $50 strike put, bid at $1.00, offers a potential 13.77% annualized return (YieldBoost) if it expires worthless (56% probability), or a $49 cost basis if assigned. Conversely, a covered call at the $55 strike, bid at $0.10, could yield 9.41% if called away by August 15th, or a 1.37% annualized boost if it expires worthless (62% probability). These options strategies present opportunities for income generation or discounted share acquisition, with implied volatilities of 47% (put) and 55% (call) against MIRM's 42% trailing twelve-month historical volatility.
Analysis of Mirum Pharmaceuticals (MIRM) options contracts reveals two distinct strategies for investors based on its current trading price of $50.36. Selling the out-of-the-money put at a $50.00 strike price for a $1.00 premium presents an opportunity to either acquire the stock at an effective cost basis of $49.00 or generate a 13.77% annualized return (YieldBoost) on the cash commitment if the option expires worthless, an outcome with a stated 56% probability. On the other hand, for current stockholders, selling a covered call at the $55.00 strike for a $0.10 premium could yield a total return of 9.41% if the stock is called away by the August 15th expiration, though it caps further upside. The probability of this call expiring worthless is 62%, which would provide a smaller 1.37% annualized return boost. Notably, the implied volatilities of the put (47%) and call (55%) are elevated compared to the stock's 42% trailing twelve-month historical volatility, suggesting that the options market is pricing in a greater potential for price movement than has been recently observed.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment